The JACIE program (Joint Accreditation Committee of ISCT-Europe and EBMT): Why and who?;Le programme JACIE (Joint Accreditation Committee of ISCT-Europe and EBMT). Pourquoi? Pour qui?

Hematologie

Volumn 14, Issue 1, 2008, Pages 48-55

  Boccaccio, Catherine ^a   Esperou, Hélène ^b   Rouard, Hélène ^a   Pautas, Cécile ^a   Robin, Marie ^c   Maury, Sébastien ^a   Cordonnier, Catherine ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b Agence de la Biomedecine   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Accreditation; Blood and marrow transplantation; Management of quality

Indexed keywords

ACCREDITATION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CELL THERAPY; CLINICAL PRACTICE; ENVIRONMENTAL FACTOR; EUROPE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CENTER; HEALTH PROGRAM; LABORATORY TEST; MEDICAL ETHICS; PHYSICIAN; REVIEW;

EID: 41549111947     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: 10.1684/hma.2008.0199     Document Type: Review

References (19)

1. FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration. 3rd Edition, 19 February 2007. ebmt.org.
2. Kelley L. The role and activities of the ISCT Regulatory Affairs Committee. Cytotherapy 2003 ; 5 : 279-83.
3. Warkentin PI. Voluntary accreditation of cellular therapies : Foundation for the Accreditation of Cellular Therapy (FACT) ; Foundation for the Accreditation of Cellular Therapy. Cytotherapy 2003 ; 5 : 299-305.
4. Warkentin PI, Nick L, Shpall EJ. FAHCT accreditation : common deficiencies during on-site inspections. Cytotherapy 2000 ; 2 : 213-20.
5. Apperley J. Just Another Cost Increasing Exercise (JACIE)? Bone Marrow Transplant 2004 ; 34 : 835-8.
6. Jarlier A, Charvet-Protat S. Can improving quality decrease hospital costs? Int J Qual Health Care 2000 ; 12 : 125-31.
7. Zahnd D, Leibundgut K, Zenhausern R, et al. Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme : a cost analysis. Bone Marrow Transplant 2004 ; 34 : 847-53.
8. Samson D, et al. Current status of JACIE accreditation in Europe : a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE). Bone Marrow Transplant 2007 ; 39 : 133-41.
9. Kvalheim G, Gratwohl A, Urbano-Ispizua A. JACIE accreditation in Europe moves ahead. JACIE national representatives. Cytotherapy 2003 ; 5 : 306-8.
10. White ASBMT. Paper on Measurement of Quality Outcomes. Committee on Hematopoietic Cell Therapy Quality Outcomes. Blood Marrow Transplant 2006 ; 12 : 594-7.
11. Arpagaus M, Leibundgut EO, Zbaren K, et al. Real-time process/quality control for HPC processing. Cytotherapy 2004 ; 6 : 505-13.
12. Burger SR. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003 ; 5 : 289-98.
13. Cornish J, Peters C. Standards of stem cell transplantation : Part I : the accreditation of paediatric stem cell transplantation centres within the EBMT ; Part II : intensive care units in paediatrie stem cell transplantation ; Part III : informed consent and sibling donor issues. Bone Marrow Transplant 2001 ; 28(Suppl. 1) : S4-S5.
14. Goldman JM. Who will regulate the regulators? Bone Marrow Transplant 2004 ; 34 : 1013-4.
15. Kvalheim G. Urbano-Ispizua, Gratwohl A. FAHCT-JACIE workshop on accreditation for blood and marrow progenitor cell processing, collection and transplantation, Barcelona, Spain. Cytotherapy 2000 ; 2 : 223-4.
16. McKenna D, Kadidlo D, Dumstad D, McCullough J. Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory. Cytotherapy 2003 ; 5 : 314-22.
17. Pamphilon D. Stem-cell harvesting and manipulation. Vox Sang 2004 ; 87(Suppl. 1) : 20-4.
18. Rowley SD. Regulation of hematopoietic stem cell processing and transplantation. Int J Hematol 2002 ; 75 : 237-45.
19. Smith L, Lowdell MW. Quality issues in stem cell and immunotherapy laboratories. Transfus Med 2003 ; 13 : 417.